MetaCap

Anixa Biosciences (ANIX) News

NASDAQ: ANIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.44-0.16 (-6.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ANIX news summary

We found 3 recent headlines mentioning Anixa Biosciences (ANIX): 1 in the past week and 2 in the past 30 days, most often from PR Newswire, Nasdaq. ANIX is making an outsized move today, down 6.15% at $2.44, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Anixa Biosciences and Curia will Develop Final Formulation for Breast Cancer Vaccine in Preparation for Phase 2 Clinical Trial", was published by PR Newswire on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Anixa Biosciences headlines

Stocks mentioned alongside ANIX

Compare ANIX